# 4D Molecular Therapeutics, Inc.: Form 8-K, filed May 25, 2023

- Company: [4D Molecular Therapeutics, Inc.](/companies/fdmt.md) (CIK 1650648)
- Form: 8-K
- Filed: 2023-05-25
- Accepted by EDGAR: May 25, 2023, 16:58 ET
- Period: 2023-05-23
- Accession: 0001193125-23-154338
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650648/000119312523154338/d350381d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650648/000119312523154338/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650648/000119312523154338/d350381d8k.htm

Filed May 25, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-154338. Last ingested by Listed: Nov 10, 2026, 16:32 ET. No prices; not investment advice.